FDA Import Refusal SCS-1717023-7/21/1 — Baxter Healthcare Corporation
The FDA refused shipment SCS-1717023-7/21/1 from Baxter Healthcare Corporation (United States) on June 15, 2022. The refused product falls under Drugs and Biologics — SODIUM CHLORIDE (PHARMACEUTIC NECESSITY - TONICITY AGENT). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 15, 2022
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 55RP55 SODIUM CHLORIDE (PHARMACEUTIC NECESSITY - TONICITY AGENT)
- Charges
- 118,3280,75